Drug reference

pacritinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1413

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(pak-RI-ti-nib) Vonjo

PDF page 1413

Functional class

Func. class.: Antineoplastic/immuno- modulating agent

PDF page 1413

Uses

USES: Myelofibrosis, intermediate- or high-risk primary or secondary (post–polycythemia vera or post–es- sential thrombocythemia) myelofibro- sis in patients with a platelet count be- low 50 × 109 cells/L

PDF page 1413

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults: PO 200 mg bid

PDF page 1413

Available forms

Available forms: Capsule 100 mg

PDF page 1413

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

pacritinib

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1413

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(pak-RI-ti-nib) Vonjo

PDF page 1413

Functional class

Func. class.: Antineoplastic/immuno- modulating agent

PDF page 1413

Uses

PDF page 1413

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adults: PO 200 mg bid

PDF page 1413

Available forms

Available forms: Capsule 100 mg

PDF page 1413

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.